Patheon has drafted in Stuart Grant as its new executive VP and CFO.
Grant takes his new role at the CDMO (contract development and manufacturing organisation) after a stint as senior VP and CFO of BioCryst Pharmaceuticals, where he created the strategy for the future operations of the company.
Of his appointment, Jim Mullen, Patheon's CEO said: "He is a proven leader and respected financial executive who will be a key player in Patheon's transformation.
“I look forward to the many contributions he will make as we continue to implement our strategy to provide superior returns to our shareholders over time."
Clinical trial and consulting services firm CTI has hired three new specialists.
Former practicing nurse at Mercy Health Partners Therese Swaisgood has joined as a clinical coding specialist.
Katelyn Westerkamp will become research associate. Prior to joining the firm she worked in education and law.
And fresh from a masters degree in science and biology from Arkansas State University, Michel Conner has joined the team as a research associate.
The firm said the new appointments are in place ready for its expected growth.
Mark Sorrentino has joined representative and management training expert CMR Institute's board of directors.
Currently executive director of global product development for CRO (contract research organisation) PPD, Sorrentino’s career in the pharma industry spans more than 15 years.
“His addition to the board will bring us both a depth of experience and fresh insights,” said Jeff Mackie, chairman of the CMR board.
“His on-the-ground practical expertise and industry leadership helps solidify our role as provider of effective educational material.”
Health Information has named Nigel Brooksby as its new deputy chairman.
In his new role, the former ABPI (Association of the British Pharmaceutical Industry) president will oversee the company’s compliance services in the UK.
He said: “During my career in the pharma industry, I have fruitlessly searched for a way to improve compliance.
“Health Information is the first to provide a cost effective way to improve compliance, and therefore clinical outcomes.”
Preclinical Oncology Services Limited (PRECOS) has hired Martin Page as its new scientific consultant.
Prior to PRECOS, he was VP and head of global oncology research for Johnson & Johnson (J&J), overseeing labs in Belgium and the US.
In his new role, Page will drive work in the evaluation of potential therapeutic agents, regimens and basic research into deriving the in vitro and in vivo screening models.
“I am extremely excited to work alongside the PRECOS team of expert scientists who are leading the way in providing robust models to enable testing of the next generation of oncology drug candidates,” said Page.
Cmed Clinical Services has appointed Geoff Fatzinger as VP of global medical and regulatory affairs.
Fatzinger was formerly executive director of regulatory affairs and strategic product development at INC Research.
He will take charge of the development of Cmed’s new medical and regulatory affairs group.
He said: “My job is to create a best in class global medical and regulatory affairs group that will provide a full cadre of strategic consulting and medical or regulatory services to clients worldwide. I am looking forward to the challenge.”